Georg Bohmig

Summary

Affiliation: Medical University of Vienna
Country: Austria

Publications

  1. Böhmig G, Bartel G, Wahrmann M. Antibodies, isotypes and complement in allograft rejection. Curr Opin Organ Transplant. 2008;13:411-8 pubmed publisher
    ..Considering the pivotal role of complement, technologies that uncover the complement-fixing ability of alloantibodies may be of particular interest for the selective detection of deleterious sensitization. ..
  2. Eskandary F, Regele H, Baumann L, Bond G, Kozakowski N, Wahrmann M, et al. A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection. J Am Soc Nephrol. 2018;29:591-605 pubmed publisher
    ..Our results reinforce the need for systematic trials to dissect the efficiency and safety of new treatments for late ABMR. ..

Detail Information

Publications2

  1. Böhmig G, Bartel G, Wahrmann M. Antibodies, isotypes and complement in allograft rejection. Curr Opin Organ Transplant. 2008;13:411-8 pubmed publisher
    ..Considering the pivotal role of complement, technologies that uncover the complement-fixing ability of alloantibodies may be of particular interest for the selective detection of deleterious sensitization. ..
  2. Eskandary F, Regele H, Baumann L, Bond G, Kozakowski N, Wahrmann M, et al. A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection. J Am Soc Nephrol. 2018;29:591-605 pubmed publisher
    ..Our results reinforce the need for systematic trials to dissect the efficiency and safety of new treatments for late ABMR. ..